newsfilter
← Latest News
Business Wire·

Fibrocell Science Appoints Greg Weaver Chief Financial Officer, Senior Vice President, Treasurer and Corporate Secretary

EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc. (NYSE MKT:FCSC), an autologous cell therapy company focused on the development of innovative products for aesthetic, medical and scientific applications, announced today the appointment of Greg Weaver as Chief Financial Officer, Senior Vice President, Treasurer and Corporate Secretary of the Company. Weaver replaces Declan Daly, who will leave the company to reside full time in Ireland. Weaver and Daly will work side by side through November 2013 to assure a smooth financial leadership transition.